Smith & Nephew SNATS Profit Margin 2006-2018 | SNN

Current and historical gross margin, operating margin and net profit margin for Smith & Nephew SNATS (SNN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Smith & Nephew SNATS net profit margin as of June 30, 2018 is 0%.
Smith & Nephew SNATS Annual Profit Margins
Smith & Nephew SNATS Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.929B $4.765B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $125.111B 19.18
Abbott Laboratories (ABT) United States $123.927B 25.11
Stryker (SYK) United States $63.616B 23.98
Boston Scientific (BSX) United States $51.104B 25.83
Baxter (BAX) United States $32.759B 21.16
Zimmer Biomet Holdings (ZBH) United States $23.343B 15.14
ResMed (RMD) United States $14.783B 28.19
Canopy Growth (CGC) Canada $9.096B 0.00
Perrigo (PRGO) Ireland $8.909B 13.52
Bio-Rad Laboratories (BIO) United States $8.086B 51.70
Aurora Cannabis (ACB) Canada $6.688B 36.63
Hill-Rom Holdings (HRC) United States $6.277B 19.90
Haemonetics (HAE) United States $5.440B 47.85
Insulet (PODD) United States $4.849B 0.00
ICU Medical (ICUI) United States $4.490B 25.04
Hutchison China MediTech (HCM) China $4.221B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.051B 0.00
Agios Pharmaceuticals (AGIO) United States $3.732B 0.00
Neogen (NEOG) United States $3.281B 49.69
National Vision Holdings (EYE) United States $3.207B 70.82
NuVasive (NUVA) United States $2.954B 27.49
Aphria (APHA) $2.817B 0.00
Quidel (QDEL) United States $2.479B 32.31
NxStage Medical (NXTM) United States $1.925B 0.00
Phibro Animal Health (PAHC) United States $1.446B 20.47
AtriCure (ATRC) United States $1.192B 0.00
Cardiovascular Systems (CSII) United States $1.046B 1507.50
VAREX IMAGING (VREX) United States $1.018B 16.63
PetIQ (PETQ) United States $0.849B 27.76
Meridian Bioscience (VIVO) United States $0.828B 26.38
OraSure Technologies (OSUR) United States $0.826B 46.52
Surmodics (SRDX) United States $0.787B 120.33
Eagle Pharmaceuticals (EGRX) United States $0.753B 24.16
Cerus (CERS) United States $0.715B 0.00
MacroGenics (MGNX) United States $0.702B 0.00
Omeros (OMER) United States $0.628B 0.00
Owens & Minor (OMI) United States $0.575B 6.50
Lantheus Holdings (LNTH) United States $0.572B 17.69
Insys Therapeutics (INSY) United States $0.548B 0.00
LeMaitre Vascular (LMAT) United States $0.526B 25.81
NanoString Technologies (NSTG) United States $0.455B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.401B 0.00
Quanterix (QTRX) United States $0.362B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.99
Cytosorbents (CTSO) United States $0.306B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.214B 289.75
Bovie Medical (BVX) United States $0.204B 0.00
Rockwell Medical (RMTI) United States $0.201B 0.00
Chimerix (CMRX) United States $0.162B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.156B 0.00
Fonar (FONR) United States $0.141B 7.11
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.091B 0.00
United-Guardian (UG) United States $0.079B 16.60
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.67
InfuSystems Holdings (INFU) United States $0.060B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Myomo (MYO) United States $0.024B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00